dismiss

Mark your calendars: the next Clean Sweep Live Auction will be on Thursday, June 21st Click to view the full catalogue

DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Posição atual:
>
> This Story


Início de uma sessão ou Registo to rate this News Story
Forward Printable StoryPrint Comment

 

 

Cardiology Homepage

Philips to acquire EPD Solutions for approx. $295 million Company has its eye on the EUR 2+ billion cardiac arrhythmia ablation market

FDA greenlights Neural Analytics' NeuralBot System Assesses risk of stroke and other neurological conditions

New algorithm predicts impact of heart transplants on survival in heart failure patients Acquires information based on 53 data points to predict rate and length of survival

Timothy J. Arens Surmodics announces leadership change and appointment of interim CFO

Early discharge associated with better outcomes after TAVR Researchers find that discharging patients within 72 hours yields clinical benefits

New tool predicts readmission among TAVR patients Recorded a score of 212 associated with a readmission rate of more than 30 percent

Penn Medicine performs first cardiac ablation procedure with the AcQMap system in US Patient is recovering nicely

How 3D printing could reduce complications after TAVR Using the pre-procedure CT data to create a model that can be implanted with a valve

Chicago mobile stroke unit expands to partnering EMS areas Equipped with a 16-slice Siemens' CT scanner

Opportunities and challenges with 3D printing in cardiology A world of potential but costs remain a barrier

Quadra Assura MP Cardiac
Resynchronization Therapy Defibrillator

FDA gives nod to MR-conditional labeling for Abbott ICD and CRT-D

por John R. Fischer , Staff Reporter
Abbott’s Quadra Assura MP Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Fortify Assura Implantable Cardioverter Defibrillator (ICD) will now come with MR-conditional labeling following FDA approval.

The nod from the FDA toward labeling enables patients in need of an ICD or a CRT-D to acquire one with less worry and anxiety in undergoing MR imaging procedures, and greater specification to ensure safety during such exams in the future.

Story Continues Below Advertisement

THE (LEADER) IN MEDICAL IMAGING TECHNOLOGY SINCE 1982. SALES-SERVICE-REPAIR

Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.



“It is important that all devices are safe and continue to function as intended in the various environments patients are exposed to,” Avi Fischer, divisional vice president of medical affairs and medical director of Abbott's cardiac rhythm management business, told HCB News. “We have made great advancements in imaging and device-based technologies and therefore, we need to ensure that patients who are receiving these treatments are safe. We also need to make sure that we are designing medical devices with true risk in mind. We need efforts to affirm what we see in the literature.”

The approvals are just two of many for Abbott, which has also received the same consent for its Assurity MRI pacemaker, Ellipse ICD and associated MRI-compatible leads. It also received CE approval in December 2016 for full body MR-conditional labeling for its Proclaim Elite Spinal Cord Stimulation.

In addition to labeling, Abbott’s Fortify Assura ICD and Quadra Assura MP CRT-D are equipped with other innovations to ensure safety, including its TailoredTherapy features, which protect against the application of unnecessary therapy and continuously monitor the condition of a lead to ensure proper delivery of appropriate therapy. The CRT-D also utilizes Abbott’s SynvAV software which adjusts therapy based on real-time changes it detects in a patient’s cardiac condition.

Fischer says that while MR-conditional labeling can be useful in relieving fear and anxiety, it is greatly believed that all cardiac implantable electronic devices (CIEDs), with or without labels, are safe for MR scanning.

“The evidence continues to support the fact that all CIEDs are safe in the MR environment when scanned using the proper protocols,” he said. “It is widely appreciated by the clinical community that this is the case even for those devices without specific MR labeling.”

Cardiology Homepage


You Must Be Logged In To Post A Comment

Anuncie
Aumente a Sua Perceção da Marca
Leilões + Vendas Privadas
Comece
O mais melhor preço
Comprar Equipamento/Peças
Encontre
O preço o mais baixo
Notícia diária
Leia
A notícia a mais atrasada
Diretório
Browse tudo
DOTmed Usuários
Ética no DOTmed
Veja o nosso
Programa das éticas
O ouro parte o programa do vendedor
Receba PH
Pedidos
Programa do negociante do serviço do ouro
Receba RFP/PS
Pedidos
Fornecedores de Healthcare
Veja tudo
Ferramentas de HCP
Trabalhos/Treinamento
Achado/suficiência
Um trabalho
Parts Hunter +EasyPay
Comece as peças
Citações
Certificado recentemente
Vista recentemente
Usuários certificados
Recentemente Rated
Vista recentemente
Usuários certificados
Central Rental
Equipamento do aluguel
Para menos
Vender Equipamentos/Peças
Comece
A maioria de dinheiro
Preste serviços de manutenção ao Forum dos técnicos
Ajuda do achado
E conselho
Simples RFP
Comece o equipamento
Citações
Mostra de comércio virtual
Serviço do achado
Para o equipamento
O acesso e o uso deste local são sujeitos aos termos e às condições do nosso OBSERVAÇÃO LEGAL & OBSERVAÇÃO DA PRIVACIDADE
Propriedade de e proprietário DOTmeda .com, Inc. Copyright ©2001-2018 DOTmed.com, Inc.
TODOS OS DIREITOS RESERVADOS